Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded the term 'Gastrointestinal stromal tumor' to the page content. Added a Resources entry linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedMinor site revision from v3.4.1 to v3.4.2 with no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page. No study details or user-facing content appear to be affected.SummaryDifference0.1%

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.